Table 1.

Pretreatment characteristics of 331 t(8;21) AML patients (N = 331)

CharacteristicsData
Age, median (range), y 41.7 (15-84) 
Sex, n (%)  
 Male 188 (57) 
 Female 143 (43) 
Diagnostic timeframe, n (%)  
 1990-1999 75 (23) 
 2000-2004 76 (23) 
 2005-2010 93 (28) 
 2010-2016 87 (26) 
Morphology, n (%)  
 AML with minimal differentiation 9 (3) 
 AML without maturation 28 (9) 
 AML with maturation 260 (84) 
 Acute myelomonocytic leukemia 11 (3) 
 Acute monoblastic/monocytic leukemia 3 (1) 
 Missing data 20 
Type of AML, n (%)  
 De novo 305 (94) 
 Secondary 10 (3) 
 Therapy related 9 (3) 
 Missing data 
Additional cytogenetic aberration, n  
 Loss of X chromosome 43 
 Loss of Y chromosome 108 
 Trisomy 8 10 
 −7/del7q 11 
 del9q 37 
 Others 64 
Bone marrow blasts  
 Mean, % 56.8 
 Missing data, n 50 
WBC count  
 Median, ×109/L 17.9 
 Range, ×109/L 0.9-153 
 Missing data, n 10 
Hemoglobin  
 Median, g/L 8.1 
 Range, g/L 2.5-15.4 
 Missing data, n 60 
Platelet count  
 Median, ×109/L 51.5 
 Range, ×109/L 3-647 
 Missing data, n 40 
CharacteristicsData
Age, median (range), y 41.7 (15-84) 
Sex, n (%)  
 Male 188 (57) 
 Female 143 (43) 
Diagnostic timeframe, n (%)  
 1990-1999 75 (23) 
 2000-2004 76 (23) 
 2005-2010 93 (28) 
 2010-2016 87 (26) 
Morphology, n (%)  
 AML with minimal differentiation 9 (3) 
 AML without maturation 28 (9) 
 AML with maturation 260 (84) 
 Acute myelomonocytic leukemia 11 (3) 
 Acute monoblastic/monocytic leukemia 3 (1) 
 Missing data 20 
Type of AML, n (%)  
 De novo 305 (94) 
 Secondary 10 (3) 
 Therapy related 9 (3) 
 Missing data 
Additional cytogenetic aberration, n  
 Loss of X chromosome 43 
 Loss of Y chromosome 108 
 Trisomy 8 10 
 −7/del7q 11 
 del9q 37 
 Others 64 
Bone marrow blasts  
 Mean, % 56.8 
 Missing data, n 50 
WBC count  
 Median, ×109/L 17.9 
 Range, ×109/L 0.9-153 
 Missing data, n 10 
Hemoglobin  
 Median, g/L 8.1 
 Range, g/L 2.5-15.4 
 Missing data, n 60 
Platelet count  
 Median, ×109/L 51.5 
 Range, ×109/L 3-647 
 Missing data, n 40 

WBC, white blood cell.

Close Modal

or Create an Account

Close Modal
Close Modal